Evidence map›Paper›PMID 37929324›Full record

ArticleCancer biology & medicine2023

Reciprocal activation of antigen-presenting cells and CAR T cells triggers a widespread endogenous anti-tumor immune response through sustained high-level IFNγ production.

Yelei Guo, Chuan Tong, Zhiqiang Wu, Yuting Lu, Yao Wang, Weidong Han

Open access · goldAbstract readEditorial
In one paragraph

Article in Cancer biology & medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yelei Guo *Department of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Chuan Tong *Department of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Zhiqiang WuDepartment of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Yuting LuDepartment of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Yao WangDepartment of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Weidong HanDepartment of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Chinese PLA General Hospital · CN

Funding

National Natural Science Foundation of China 31991171National Natural Science Foundation of China 81830002 to W.H.National Natural Science Foundation of China 82102892 to C.T.National Natural Science Foundation of China 82150108
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsAntigen-Presenting CellsHumansImmunityT-Lymphocytes

Identifiers

PMID37929324
PMCPMC10690879
OpenAlexW4388420636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.